4//SEC Filing
Montecalvo Antonio S. 4
Accession 0001062993-22-007530
CIK 0001661181other
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 6:42 PM ET
Size
14.0 KB
Accession
0001062993-22-007530
Insider Transaction Report
Form 4
Montecalvo Antonio S.
Vice President, Health Policy
Transactions
- Exercise/Conversion
Class A Common Stock
2022-03-10$3.46/sh+46,103$159,516→ 119,324 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-10−46,103→ 55,397 totalExercise: $3.46Exp: 2027-05-04→ Class A Common Stock (46,103 underlying) - Exercise/Conversion
Class A Common Stock
2022-03-10$3.46/sh+22,401$77,507→ 141,725 total - Sale
Class A Common Stock
2022-03-09$8.52/sh−10,000$85,200→ 73,221 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-10−22,401→ 78,175 totalExercise: $3.46Exp: 2027-05-04→ Class A Common Stock (22,401 underlying) - Sale
Class A Common Stock
2022-03-10$8.39/sh−97,436$817,488→ 44,289 total
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $8.50 to $8.54, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $8.34 to $8.42, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- [F3]The shares underlying the option vested or shall vest 20% annually beginning on January 1, 2018.
- [F4]The shares underlying the option vested or shall vest 20% annually beginning on December 31, 2017.
Issuer
Organogenesis Holdings Inc.
CIK 0001661181
Entity typeother
Related Parties
1- filerCIK 0001759261
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 6:42 PM ET
- Size
- 14.0 KB